Cargando…
Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19
Common clinical features of patients with Coronavirus disease-2019 (COVID-19) vary from fever, to acute severe respiratory distress syndrome. Several laboratory parameters are reported as indicators of COVID-19 severity. We hereby describe the possible novel severity biomarkers for COVID-19, CD11b+C...
Autores principales: | Alberca, Ricardo Wesley, Andrade, Milena Mary de Souza, Branco, Anna Cláudia Calvielli Castelo, Pietrobon, Anna Julia, Pereira, Nátalli Zanete, Fernandes, Iara Grigoletto, Oliveira, Luana de Mendonça, Teixeira, Franciane Mouradian Emidio, Beserra, Danielle Rosa, de Oliveira, Emily Araujo, Gozzi-Silva, Sarah Cristina, Ramos, Yasmim Álefe Leuzzi, de Brito, Cyro Alves, Arnone, Marcelo, Orfali, Raquel Leao, Aoki, Valeria, Duarte, Alberto Jose da Silva, Sato, Maria Notomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592395/ https://www.ncbi.nlm.nih.gov/pubmed/33178720 http://dx.doi.org/10.3389/fmed.2020.580677 |
Ejemplares similares
-
Immunosuppressive role of CD11b(+)CD33(+)HLA‐DR(−) myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
por: Hyun, Shin Young, et al.
Publicado: (2020) -
Clinical significance of peripheral blood CD11b(+)/CD33(+)/HLA-DR(-) myeloid cells in infants and children with infectious diseases and increased CRP
por: Latifi, Aysan, et al.
Publicado: (2020) -
Expression of CD1a, CD207, CD11b, CD11c, CD103, and HLA-DR receptors on the surface of dendritic cells in the skin of patients with atopic dermatitis
por: Ścibior, Kinga, et al.
Publicado: (2017) -
Antiretroviral Therapy Normalizes Autoantibody Profile of HIV Patients by Decreasing CD33(+)CD11b(+)HLA-DR(+) Cells: A Cross-Sectional Study
por: Meng, Zhefeng, et al.
Publicado: (2016) -
Intratumoral HLA-DR(−)/CD33(+)/CD11b(+) Myeloid-Derived Suppressor Cells Predict Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Hasnis, Erez, et al.
Publicado: (2020)